Abstract
New drugs selective for histamine H3-receptors can be used to establish that these receptors are involved in the feedback control ofhistamine synthesis and release, and to demonstrate their distribution in the brain and peripheral tissues. These drugs provide new tools for affecting physiological and possibly pathological conditions in which histamine is involved.
Similar content being viewed by others
References
1. Plaut, M. & Lichtenstein, L. M. in Pharmacology of Histamine Receptors (eds Ganellin, C. R. & Parsons, M. E.) 392–435 (Wright PSG, Bristol 1982). 2. Hakanson, R. & Owman, C. Life Sci. 6, 759–766 (1967). 3. Schwartz, J.-C., Garbarg, M. & Pollard, H. in Handbook of Physiology, the Nervous System, Vol. IV: Intrinsic Regulatory Systems of the Brain (eds Bloom, F. E., Mountcastle, W. B. & Geiger, S. R.) 257–316 (American Physiological Society, Bethesda, 1986). 4. Happola, O., Soinila, S., Paivarinta, H., Panula, P. & Eranko- d. Histochemistry 82, 1–3 (1985). 5. Berridge, M. J. & Irvine, R. F. Nature 312, 315–321 (1984). 6. Hegstrand, L. R., Kanof, P. D. & Greengard, P. Nature 260, 163–165 (1976). 7. Black, J. W., Duncan, W. A. M., Durant, C. J., Ganellin, C. R. & Parsons, M. E. Nature 236,385–390(1972). 8. Arrang, J.-M., Garbarg, M. & Schwartz, J.-C. Nature 302, 832–837 (1983). 9. Arrang, J.-M., Garbarg, M. & Schwartz, J.-C. Neuroscience 15, 553–562 (1985). 10. Arrang, J.-M., Garbarg, M. & Schwartz, J.-C. in Frontiers in Histamine Research (eds Ganellin, C. R. & Schwartz, J.–C.) 143–153 (Pergamon, Oxford, 1985). 11. Ganellin, C. R. in Pharmacology of Histamine Receptors (ed Ganellin, C. R. & Parsons, M. E.) 10–102 (Wright PSG, Bristol, 1982). 12. Schunack, W., Schwarz, S., Gerhard, G., Buyiiktimkin, S. & Elz, S. in Frontiers in Histamine Research (eds Ganellin, C. R. & Schwartz, J.-C) 39–46 (Pergamon, Oxford, 1985). 13. Arrang, J.-M., Schwartz, J.-C. & Schunack, W. Eur. J. Pharmac. 117, 109–114 (1985). 14. Schwartz, J.-C., Arrang, J.-M., Garbarg, M. & Korner, M. J. exp. Biol. 124, 203–224 (1986). 15. Arrang, J.-M. et al. Eur. J. Pharmac. Ill, 73–84 (1985). 16. Gaddum, J. H. / PhysioL, Lond. 89. 7P–9P (1937). 17. Cheng, Y. C. & Prusoff, W. H. Biochem. Pharmac. 22, 3099–3108 (1973). 18. Baudry, M., Martres, M. P. & Schwartz, J.-C. Brain Res. 116, 111–124 (1976). 19. U'Prichard, D. C., Greenberg, D. A. & Snyder, S. H. Molec. Pharmac. 13, 454–473 (1977). 20. Yamamura, H. I. & Snyder, S. H. Molec. Pharmac. 10, 861–867 (1974). 21. Pert, C. B. & Snyder, S. H. Science 179, 1011–1014 (1973). 22. Martres, M. P., Bouthenet, M. L., Sales, N., Sokoloff, P. & Schwartz, J.-C. Science 228, 752–755 (1985). 23. Peroutka, S. J. & Snyder, S. H. Molec. Pharmac. 16, 687–699 (1979). 24. Leysen, J. E., Niemegeers, C. J. E., Tollenaere, J. P. & Laduron, P. M. Nature 272,168–171 (1978). 25. Schwartz, J.-C., Arrang, J.-M., Garbarg, M. & Schunack, W. in Innovative Approaches in Drug Research (ed. Harms, A. F.) 73–89 (Elsevier, Amsterdam, 1986). 26. Garbarg, M., Barbin, G., Rodergas, E. & Schwartz, J.-C. /. Neurochem. 35,1045–1052 (1980). 27. Watanabe, T. et al. Neurosci. Lett. 39, 249–254 (1983). 28. Steinbusch, H. W. M. & Mulder, A. H. in Frontiers in Histamine Research (eds Ganellin, C. R. & Schwartz, J.-C.) 119–130 (Pergamon, Oxford, 1985). 29. Eyre, P. & Chand, N. in Pharmacology of Histamine Receptors (eds Ganellin, C. R. & Parsons, M. E.) 298–322 (Wright PSG, Bristol, 1982). 30. Pearce, F. L. et al. in Frontiers in Histamine Research (eds Ganellin, C. R. & Schwartz, J.-C.) 411–422 (Pergamon, Oxford, 1985). 31. Hill, S. J., Emson, P. C. & Young, J. M. /. Neurochem. 31, 997–1004 (1978). 32. Tran, V. T., Chang, R. S. L. & Snyder, S. H. Proc. natn. Acad. Sci. U.S.A. 75,6290–6294 (1978). 33. Gajtkowski, G. A., Norris, D. B., Rising, T. J. & Wood, T. P. Nature 304, 65–67 (1983). 34. Langer, S. Z. Br. J. Pharmac. 60, 481–497 (1977). 35. Starke, K. A. Rev. Pharmac. Tox. 21, 7–30 (1981). 36. Stjarne, L. in Chemical Neurotransmission 75 Years. Karolinska Institutet, Nobel Conference No. 2 (eds Stjarne, L., Hedqvist, P., Lagercrantz, H. & Wennmalm, A.) 257–272 (Academic, London, 1981). 37. Schoffelmeer, A. N. M., Wierenga, E. A. & Mulder, A. H. / Neurochem. 46, 1711–1717 (1986). 38. Schwartz, J.-C. A. Rev. Pharmac. Tox. 17, 325–339 (1977). 39. Vanni-Mercier, G., Sakai, K. & Jouvet, M. C.r. hebd. Seanc. Acad. Sci., Paris 298, 195–200 (1984). 40. Lin, J.-S., Sakai, K. & Jouvet, M. C.R. hebd. Seanc. Acad. Sci., Paris 303, 469–474 (1986). 41. Gross, P. M. in Frontiers in Histamine Research (eds Ganellin, C. R. & Schwartz, J.-C.) 341–352 (Pergamon, Oxford, 1985). 42. Quach, T. T., Duchemin, A. M., Rose, C. & Schwartz, J.-C. Molec. Pharmac. 17, 301–308 (1980). 43. Tuomisto, J. & Mannisto, P. Pharmac. Rev. 37, 249–332 (1985). 44. Gerhard, G. & Schunack, W. Arch. Pharm., Weinheim 313, 709–714 (1980). 45. Schunack, W. Arzneimittel-Forsch. 28, 2199–2202 (1978). 46. Kollonitsch, J. et al. Nature 274, 906–908 (1978). 47. Garbarg, M., Pollard, H., Quach, T. T. & Schwartz, J.-C. in Methods in Biogenic Amines Research (eds Parvez, S., Nagatsu, T., Nagatsu, I. & Parvez, H.) 623–662 (Elsevier, Amsterdam, 1983). 48. Saeki, K., Oishi, R. & Nishibori, M. in Frontiers in Histamine Research (eds Ganellin, C. R. & Schwartz, J.-C.) 173–184 (Pergamon, Oxford, 1985). 49. Parker, R. B. & Waud, D. R. J. Pharmac. exp. Therap. 177, 1–12 (1971). 50. Paxinos, G. & Watson, C. The Rat Brain in Stereotaxic Coordinates (Academic, London, 1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arrang, JM., Garbarg, M., Lancelo, JC. et al. Highly potent and selective ligands for histamine H3-receptors. Nature 327, 117–123 (1987). https://doi.org/10.1038/327117a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/327117a0
- Springer Nature Limited
This article is cited by
-
The impact of pitolisant, an H3 receptor antagonist/inverse agonist, on perirhinal cortex activity in individual neuron and neuronal population levels
Scientific Reports (2022)
-
Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials
CNS Drugs (2022)
-
Histaminrezeptoren bei chronisch-entzündlichen Erkrankungen der Nase und Nasennebenhöhlen
HNO (2019)
-
High specific activity tritiation of various methylated histamine analogues
Journal of Radioanalytical and Nuclear Chemistry (2019)
-
The histamine H3 receptor antagonist thioperamide rescues circadian rhythm and memory function in experimental parkinsonism
Translational Psychiatry (2017)